2022年版醫保藥(yao)(yao)品目(mu)錄(lu)顯示，目(mu)前中國共收(shou)載西(xi)(xi)藥(yao)(yao)和中成(cheng)藥(yao)(yao)達2967種(zhong)，其中西(xi)(xi)藥(yao)(yao)1586種(zhong)，中成(cheng)藥(yao)(yao)1381種(zhong)。中藥(yao)(yao)飲片未作調整，仍(reng)為(wei)892種(zhong)。此(ci)次共111個藥(yao)(yao)品新增(zeng)進入目(mu)錄(lu)，3個藥(yao)(yao)品被(bei)調出目(mu)錄(lu)。

本次調(diao)整新(xin)增的111個藥(yao)(yao)品(pin)名(ming)單里，其中(zhong)西藥(yao)(yao)類(lei)(lei)有3種(zhong)(zhong)(zhong)、協議(yi)期內(nei)談判(pan)藥(yao)(yao)品(pin)部分 (一)西藥(yao)(yao)類(lei)(lei)有83種(zhong)(zhong)(zhong)、協議(yi)期內(nei)談判(pan)藥(yao)(yao)品(pin)部分 (二)中(zhong)成藥(yao)(yao)類(lei)(lei)有8種(zhong)(zhong)(zhong)，競(jing)價藥(yao)(yao)品(pin)部分有17種(zhong)(zhong)(zhong)。

2022醫保談判(pan)目錄新增的(de)74個談判(pan)藥(yao)(yao)品涉及(ji)21個臨床組別，其(qi)中罕見病用(yong)(yong)藥(yao)(yao)7種(zhong)，新冠肺炎治療用(yong)(yong)藥(yao)(yao)2種(zhong)，其(qi)他領域用(yong)(yong)藥(yao)(yao)12種(zhong)，腫瘤用(yong)(yong)藥(yao)(yao)18種(zhong)，丙肝(gan)、艾滋病等抗(kang)毒感染用(yong)(yong)藥(yao)(yao)15種(zhong)，高血壓、糖(tang)尿病、高血脂等慢性病用(yong)(yong)藥(yao)(yao)20種(zhong)。